NIH-funded research R01 grant

Identifying childhood cancer survivors at risk for heart problems using AI and ECG data.

Official title: Early Identification of Childhood Cancer Survivors at High Risk for Late Onset Cardiomyopathy: An Artificial Intelligence Approach utilizing Electrocardiography

Funded at Wake Forest University Health Sciences · NIH-11059172 · Data updated 2026-11-12

This study is working on a smart computer program that looks at heart test results to help find childhood cancer survivors who might be at risk for heart problems later on, so they can get the care they need to stay healthy.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWake Forest University Health Sciences
NIH-funded
Lab location1 site (Winston-Salem, United States)
Project startApril 15, 2022
Project endMarch 31, 2026
Funding year2025
Award (this year)$480,774
NIH project number5R01CA261834-04
Project IDNIH-11059172 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are childhood cancer survivors who have received anthracycline chemotherapy or chest-directed radiation and are currently under active follow-up care.

Less likely to help

Patients who have not undergone treatment with anthracycline chemotherapy or chest-directed radiation may not benefit from this research.

What this research studies

This research aims to develop an artificial intelligence tool that analyzes electrocardiogram (ECG) data to identify childhood cancer survivors who are at high risk for developing cardiomyopathy, a serious heart condition. Given that many childhood cancer survivors treated with certain chemotherapy drugs face long-term cardiovascular risks, this project seeks to enhance early detection methods beyond current screening guidelines. By utilizing AI, the researchers hope to predict which patients may develop heart issues in the future, allowing for timely interventions to improve their quality of life.

Why it matters

Potential benefit: If successful, this research could lead to earlier identification and management of heart problems in childhood cancer survivors, significantly improving their long-term health outcomes.

How similar studies have gone: Previous research has demonstrated success in using AI to predict cardiomyopathy in similar patient populations, indicating a promising approach for this project.

Where this research is happening

  • Wake Forest University Health Sciences
    Winston-Salem, United States
    Active

Researchers

  • Principal investigator: Akbilgic, Oguz — Wake Forest University Health Sciences
  • Study coordinator: Akbilgic, Oguz

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.